04.12.2012 Views

LIBRO-CONGRESO-CITRUS

LIBRO-CONGRESO-CITRUS

LIBRO-CONGRESO-CITRUS

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

S20O06<br />

Evaluation of the anticancer activity on prostate cancer by low molecular weight citrus pectin<br />

Lu S. 1 , Chen J. 1 , Yin Y. 2 , Xia Q. 1 , Zhang J. 1 , and Yang Y. 1<br />

1 Zhejiang Academy of Agricultural Sciences (ZAAS), Institute of Food Science, China; and 2 Zhejiang Normal University (ZNU), College<br />

of Chemistry and Life Science, China. lushengmin@hotmail.com<br />

Low molecular weight citrus pectin (LMCP) was prepared by treating commercial citrus pectin (CP)<br />

at 121ºC for 30 min and then lyophilized. The molecular properties including weight, galacturonic acid<br />

content and degree of esterification (DE) of LMCP and CP were determined, and their resistance capacity<br />

on hormone-independent prostate cancer PC3 cells in vitro was investigated as well. Galatin-3 levels in<br />

PC3 cells were detected using Northern blotting. The results indicated that the average molecular weight<br />

(Mp), galacturonic acid content and DE of LMCP were 6685u, 78% and 38% respective in LMCP compared<br />

to 55,654 u, 64% and 59% respectively in CP. Both CP and LMCP had inhibitive activities to PC3 vitality in a<br />

dose-dependent manner, however, LMCP had stronger inhibition capacity against PC3 cells. The inhibition<br />

of LMCP in middle dose (2.5 mg/mL) to PC3 cell viability was 38%, and the inhibition rate increased to 80%<br />

~90% when treated with LMCP in high dose (5-10 mg/mL). The IC50 for inhibiting PC3 cells proliferation was<br />

3.55±0.44 mg/mL. Galactin-3 level in PC3 cells treated with 10 mg/mL LMCP had no significant difference<br />

with that in the control cells, which indicated that the anticancer activity of LMCP on PC3 cells might have<br />

no relation with galactin-3 levels.<br />

S20O07<br />

A molecular approach to characterize the accumulation of ascorbic acid in citrus fruits<br />

Alós E, Legaz P., Rodrigo M.J, and Zacarías L.<br />

Instituto de Agroquímica y Tecnología de Alimentos (IATA-CSIC), Food Science, Spain. ealos@iata.csic.es<br />

Citrus fruits are widely recognized by their concentration of vitamin C and therefore as one of the major<br />

sources of ascorbic acid (AsA) for human nutrition and health. Moreover, AsA is the most abundant<br />

antioxidant present in plant cells and plays important roles in many developmental and stress processes. The<br />

biosynthesis of AsA in higher plants has been elucidated recently and to date four, somehow interlinked, AsA<br />

biosynthetic pathways have been proposed; namely the L-Galactose, the L-Gulose, the Myo-inositol and the<br />

D-Galacturonic acid pathways. Despite the relevance of AsA in citrus fruits, the biochemical and molecular<br />

bases of its synthesis and accumulation are almost unknown. Therefore, the objective of the present work<br />

has been to initiate a molecular characterization of the metabolic pathways involved in the synthesis and<br />

accumulation of AsA in citrus fruits in order to understand its regulation and to identify potential key steps of<br />

the pathway. Nine genes belonging to the four biosynthetic pathways and also to the degradation and recycling<br />

of AsA have been selected and their expression characterized in peel and pulp of fruit during development<br />

and maturation. Results in fruits of selected citrus varieties indicate that changes in AsA content appear to be<br />

regulated not only by de novo biosynthesis of AsA but also by degradation, recycling and transport, and that<br />

different mechanisms may operate in peel and pulp.<br />

S20P01<br />

Protective effect of grapefruit naringin on atherosclerosis development and identification of the<br />

underlying mechanisms<br />

Milenkovic D. 1 , Chanet A. 1 , Habauzit V. 2 , Bennetau-Pelissero C. 3 , Berard A.M. 4 , Mazur A. 1 , and Morand C. 1<br />

1 INRA, UMR1019, Unité Nutrition Humaine, France; 2 Centre Investigation Clinique, CIC-CPC INSERM 501, Centre Hospitalier<br />

Universitaire, Clermont-Ferrand, France; 3 Université de Bordeaux, ENITA Bordeaux 1, France; and 4 ERU « Facteurs de risque vasculaires<br />

», CHU-Université de Bordeaux, France. christine.morand@clermont.inra.fr<br />

The aim of this study was to investigate the anti-atherogenic effect of naringin in a mouse model of<br />

hypercholesterolemia (mice fed a high-fat/high-cholesterol diet) and decipher its molecular targets in aorta<br />

using nutrigenomic approach. Dietary naringin supplementation (0.02% wt/wt) for 18 weeks reduced plaque<br />

progression by 41% compared to controls as well the concentrations of several biomarkers of endothelial<br />

XII INTERNATIONAL <strong>CITRUS</strong> CONGRESS 2012 - 345<br />

S20

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!